Fifth Lane Capital »

Chemours shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Chemours (CC) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Chemours

Tip: Access up to 7 years of quarterly data

All positions including Chemours held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemours by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $560k 48k 11.79

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hologic Call Option (HOLX)
Renatus Tactical Acquis Shs Cl A (RTAC)
Avidity Biosciences Ord (RNA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cantor Equity Partners Iv Shs Cl A (CEPF)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Amazon Call Option (AMZN)
Cantor Equity Partners Ii Cl A Ord Shs (CEPT)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Futurecrest Acquisition Cl A Ord Shs (FCRS)
Btc Dev Corp Ord Shs Cl A (BDCI)
UnitedHealth (UNH)

View all positions for Fifth Lane Capital

Top funds holding Chemours

BlackRock
Vanguard Group
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
Millennium Management
FMR
Goldman Sachs Group
Cooper Creek Partners Management
American Century Companies
UBS Group
Geode Capital Management
Scopia Management
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Chemours